Viewing Study NCT00003760


Ignite Creation Date: 2025-12-25 @ 2:10 AM
Ignite Modification Date: 2025-12-27 @ 11:40 PM
Study NCT ID: NCT00003760
Status: COMPLETED
Last Update Posted: 2012-08-09
First Post: 1999-11-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Irofulvene in Treating Patients With Stage III or Stage IV Pancreatic Cancer
Sponsor: The University of Texas Health Science Center at San Antonio
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Pancreatic Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None stage III pancreatic cancer View
None stage IV pancreatic cancer View
None recurrent pancreatic cancer View
None adenocarcinoma of the pancreas View